Robert W. Baird Downgrades Pharmasset to Neutral

Robert W. Baird has downgraded Pharmasset (NASDAQ:
VRUS
) from Outperform to Neutral.
Market News and Data brought to you by Benzinga APIs

Comments
Loading...